Cargando…
BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats
Tumor hypoxia is an established facilitator of survival adaptation and mesenchymal transformation in glioblastoma (GBM). The underlying mechanisms that direct hypoxia-mediated survival in GBM habitats are unclear. We previously identified BIRC3 as a mediator of therapeutic resistance in GBM to stand...
Autores principales: | Wang, Dapeng, Berglund, Anders E., Kenchappa, Rajappa S., MacAulay, Robert J., Mulé, James J., Etame, Arnold B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570925/ https://www.ncbi.nlm.nih.gov/pubmed/28839258 http://dx.doi.org/10.1038/s41598-017-09503-8 |
Ejemplares similares
-
BIRC3 is a novel driver of therapeutic resistance in Glioblastoma
por: Wang, Dapeng, et al.
Publicado: (2016) -
A Novel Role of BIRC3 in Stemness Reprogramming of Glioblastoma
por: Wu, Qiong, et al.
Publicado: (2021) -
Paradoxical epigenetic regulation of XAF1 mediates plasticity towards adaptive resistance evolution in MGMT-methylated glioblastoma
por: Wu, Qiong, et al.
Publicado: (2019) -
Epigenetic Activation of TUSC3 Sensitizes Glioblastoma to Temozolomide Independent of MGMT Promoter Methylation Status
por: Wu, Qiong, et al.
Publicado: (2023) -
The Impact of Epigenetic Modifications on Adaptive Resistance Evolution in Glioblastoma
por: Wu, Qiong, et al.
Publicado: (2021)